CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler.

Aerolizer Capsule aperture Dry powder inhaler (DPI) computational fluid dynamics (CFD) discrete element method (DEM)

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Nov 2023
Historique:
received: 05 07 2023
revised: 02 10 2023
accepted: 24 10 2023
medline: 20 11 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: ppublish

Résumé

Capsule based dry powder inhalers (DPIs) often require piercing of the capsule before inhalation, and the characteristics of the apertures (punctured holes) affect air flow and the release of powders from the capsule. This work develops a numerical model based on the two-way coupling of computational fluid dynamics and discrete element method (CFD-DEM) to investigate the effect of aperture size on powder dispersion in the Aerolizer® device loaded with only carrier particles (lactose). Powders (carrier particles) in the size range 60-140 μm (d

Identifiants

pubmed: 37890648
pii: S0378-5173(23)00977-8
doi: 10.1016/j.ijpharm.2023.123556
pii:
doi:

Substances chimiques

Aerosols 0
Powders 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123556

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Qixuan Zhu (Q)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW 2052, Australia.

Maziar Kakhi (M)

Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Chandana Jayasundara (C)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW 2052, Australia.

Ross Walenga (R)

Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Srinivas Ravindra Babu Behara (SRB)

Division of Immediate and Modified Release Products III, Office of Lifecycle Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Hak-Kim Chan (HK)

Advanced Drug Delivery Group, School of Pharmacy, The University of Sydney, NSW 2006, Australia.

Runyu Yang (R)

School of Materials Science and Engineering, University of New South Wales, Sydney, NSW 2052, Australia. Electronic address: r.yang@unsw.edu.au.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Humans Surgical Staplers Surgical Stapling Postoperative Complications Treatment Outcome
Calcium Carbonate Sand Powders Construction Materials Materials Testing

Classifications MeSH